The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo

References

• Leang SK, et al. Influenza antiviral resistance in the Asia-Pacific region during 2011. Antiviral Res. 2013;97:206–210. doi: 10.1016/j.antiviral.2012.12.016
   PubMed Web of Science ®Google Scholar
• Fauci AS. Emerging and re-emerging infectious diseases: influenza as a prototype of the host-pathogen balancing act. Cell. 2006;124:665–670. doi: 10.1016/j.cell.2006.02.010
   PubMed Web of Science ®Google Scholar
• Hurt AC, Butler J, Kelso A, et al. Influenza antivirals and resistance: The next 10 years? Expert Rev Anti Infect Ther. 2012;10:1221–1223. doi: 10.1586/eri.12.125
   PubMed Web of Science ®Google Scholar
• Miller MS, Palese P. Peering into the crystal ball: influenza pandemics and vaccine efficacy. Cell. 2014;157:294–299. doi: 10.1016/j.cell.2014.03.023
   PubMed Web of Science ®Google Scholar
• de Chassey B, Meyniel-Schicklin L, Vonderscher J, et al. Virus-host interactomics: new insights and opportunities for antiviral drug discovery. Genome Med. 2014;6:1–14. doi: 10.1186/s13073-014-0115-1
   PubMed Web of Science ®Google Scholar
• Villalón-Letelier F, Brooks AG, Saunders PM, et al. Host cell restriction factors that limit influenza a infection. Viruses. 2017;9:1–18. doi: 10.3390/v9120376
   Web of Science ®Google Scholar
• Edinger TO, Pohl MO, Stertz S. Entry of influenza A virus: host factors and antiviral targets. J. Gen. Virol. 2014;95:263–277. doi: 10.1099/vir.0.059477-0
   PubMed Web of Science ®Google Scholar
• Johannsdottir HK, Mancini R, Kartenbeck J, et al. Host cell factors and functions involved in vesicular stomatitis virus entry. J Virol. 2009;83:440–453. doi: 10.1128/JVI.01864-08
   PubMed Web of Science ®Google Scholar
• Bouvier NM, Palese P. The biology of influenza viruses. Vaccine. 2008;26:49–53. doi: 10.1016/j.vaccine.2008.07.039
   PubMed Web of Science ®Google Scholar
• Musiol A, Gran S, Ehrhardt C, et al. Annexin A6-balanced late endosomal cholesterol controls influenza a replication and propagation. MBio. 2013;4:1–11. doi: 10.1128/mBio.00608-13
   Web of Science ®Google Scholar
• Urata S, Uno Y, Kurosaki Y, et al. The cholesterol, fatty acid and triglyceride synthesis pathways regulated by site 1 protease (S1P) are required for efficient replication of severe fever with thrombocytopenia syndrome virus. Biochem Biophys Res Commun. 2018;503(2):631–636. doi: 10.1016/j.bbrc.2018.06.053
   PubMed Web of Science ®Google Scholar
• Rivero-juarez A, et al. Differential Timing of cholesterol increase during successful HCV therapy : impact of type of drug Combination. J Acquir Immune Defic Syndr. 2018;78:437–440. doi: 10.1097/QAI.0000000000001691
   PubMed Web of Science ®Google Scholar
• Hofmann S, et al. Complex lipid metabolic remodeling is required for efficient hepatitis C virus replication. Biochim Biophys Acta. 2018;1863:1041–1056. doi: 10.1016/j.bbalip.2018.06.002
   PubMed Web of Science ®Google Scholar
• Zhu L, et al. Both ganglioside GM2 and cholesterol in the cell membrane are essential for Bombyx mori Cypovirus cell entry. Dev Comp Immunol. 2018;88:161–168. doi: 10.1016/j.dci.2018.07.011
   PubMed Web of Science ®Google Scholar
• Doms A, Sanabria T, Hansen JN, et al. 25-Hydroxycholesterol production by the cholesterol-25-Hydroxylase interferon-stimulated gene restricts mammalian Reovirus infection. J Virol. 2018;92:e01047–18. doi: 10.1128/JVI.01047-18
   PubMed Web of Science ®Google Scholar
• York AG, et al. Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling. Cell. 2015;163:1716–1729. doi: 10.1016/j.cell.2015.11.045
   PubMed Web of Science ®Google Scholar
• Brass AL, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and Dengue virus. Cell. 2009;139:1243–1254. doi: 10.1016/j.cell.2009.12.017
   PubMed Web of Science ®Google Scholar
• Amini-Bavil-Olyaee S, et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe. 2013;13:452–464. doi: 10.1016/j.chom.2013.03.006
   PubMed Web of Science ®Google Scholar
• Desai TM, et al. IFITM3 restricts influenza A virus entry by blocking the formation of fusion Pores following virus-endosome Hemifusion. PLoS Pathog. 2014;10:e1004048. doi: 10.1371/journal.ppat.1004048
   PubMed Web of Science ®Google Scholar
• Sun X, Whittaker GR. Role for influenza virus envelope cholesterol in virus entry and infection. J Virol. 2003;77:12543–12551. doi: 10.1128/JVI.77.23.12543-12551.2003
   PubMed Web of Science ®Google Scholar
• Dekkers BGJ, et al. Therapeutic drug monitoring of posaconazole: an update. Curr Fungal Infect Rep. 2016;10:51–61. doi: 10.1007/s12281-016-0255-4
   PubMed Web of Science ®Google Scholar
• Lepesheva GI, Waterman MR. Sterol 14α-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochimica et Biophysica Acta. 2007;1770:467–477. doi: 10.1016/j.bbagen.2006.07.018
   PubMed Web of Science ®Google Scholar
• Trinh MN, et al. Triazoles inhibit cholesterol export from lysosomes by binding to NPC1. Proc Natl Acad Sci. 2017;114:89–94. doi: 10.1073/pnas.1619571114
   PubMed Web of Science ®Google Scholar
• Kühnl A, et al. Late endosomal/lysosomal cholesterol accumulation is a host cell-protective mechanism inhibiting endosomal escape of influenza A virus. MBio. 2018;9:e01345–18. doi: 10.1128/mBio.01345-18
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4
   PubMed Web of Science ®Google Scholar
• Krischuns T, et al. Phosphorylation of TRIM28 enhances the expression of IFN-beta and proinflammatory cytokines during HPAIV infection of human lung epithelial cells. Front Immunol. 2018;9:2229. doi: 10.3389/fimmu.2018.02229
   PubMed Web of Science ®Google Scholar
• Jiao P, Fan W, Sun Y, et al. [Research advance of influenza B viruses]. Sheng Wu Gong Cheng Xue Bao. 2018;34:821–831.
   PubMedGoogle Scholar
• Desmyter J, Melnick JL, Rawls WE. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J Virol. 1968;2:955–961.
   PubMed Web of Science ®Google Scholar
• Holzinger D, et al. Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol. 2007;81:7776–7785. doi: 10.1128/JVI.00546-06
   PubMed Web of Science ®Google Scholar
• Le Blanc I, et al. Endosome-to-cytosol transport of viral nucleocapsids. Nat Cell Biol. 2005;7:653–664. doi: 10.1038/ncb1269
   PubMed Web of Science ®Google Scholar
• Sobo K, et al. Late endosomal cholesterol accumulation leads to impaired intra-endosomal trafficking. PLoS One. 2007;2:e851. doi: 10.1371/journal.pone.0000851
   PubMed Web of Science ®Google Scholar
• White JM, Whittaker GR. Fusion of enveloped viruses in endosomes. Traffic. 2016;17:593–614. doi: 10.1111/tra.12389
   PubMed Web of Science ®Google Scholar
• Heitzig N, et al. Cooperative binding promotes demand-driven recruitment of AnxA8 to cholesterol-containing membranes. Biochim Biophys Acta – Mol Cell Biol Lipids. 2018;1863:349–358. doi: 10.1016/j.bbalip.2018.01.001
   PubMed Web of Science ®Google Scholar
• Stauffer S, et al. Stepwise priming by acidic pH and a high K+ concentration is required for efficient uncoating of influenza A virus cores after penetration. J Virol. 2014;88:13029–13046. doi: 10.1128/JVI.01430-14
   PubMed Web of Science ®Google Scholar
• Nair A, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27–31. doi: 10.4103/0976-0105.177703
   PubMedGoogle Scholar
• Taubenberger JK, Morens DM. 1918 influenza: The mother of all pandemics. Emerg Infect. Dis. 2006;12:15–22. doi: 10.3201/eid1209.05-0979
   PubMed Web of Science ®Google Scholar
• Dawood FS, et al. Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study. Lancet Infect Dis. 2012;12:687–695. doi: 10.1016/S1473-3099(12)70121-4
   PubMed Web of Science ®Google Scholar
• Scheuch G, et al. Targeting intracellular signaling as an antiviral strategy: Aerosolized LASAG for the treatment of influenza in hospitalized patients. Emerg Microbes Infect. 2018;7:21. doi: 10.1038/s41426-018-0023-3
   PubMed Web of Science ®Google Scholar
• Haasbach E, et al. The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in vitro and provides a prolonged treatment window compared to standard of care in vivo. Antiviral Res. 2017;142:178–184. doi: 10.1016/j.antiviral.2017.03.024
   PubMed Web of Science ®Google Scholar
• Droebner K, Pleschka S, Ludwig S, et al. Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Res. 2011;92:195–203. doi: 10.1016/j.antiviral.2011.08.002
   PubMed Web of Science ®Google Scholar
• O’Neill LAJ. How low cholesterol Is Good for anti-viral Immunity. Cell. 2015;163:1572–1574. doi: 10.1016/j.cell.2015.12.004
   PubMed Web of Science ®Google Scholar
• Cianciola NL, Chung S, Manor D, et al. Adenovirus modulates toll-like receptor 4 signaling by reprogramming ORP1L-VAP protein contacts for cholesterol transport from endosomes to the. J Virol. 2017;91:1–23. doi: 10.1128/JVI.01904-16
   Web of Science ®Google Scholar
• Kielian MC, Helenius A. Role of cholesterol in fusion of Semliki Forest virus with membranes. J Virol. 1984;52:281–283.
   PubMed Web of Science ®Google Scholar
• Ivashkiv LB, Donlin LT. Regulation of type i interferon responses. Nat Rev Immunol. 2014;14:36–49. doi: 10.1038/nri3581
   PubMed Web of Science ®Google Scholar
• de Vries E, et al. Dissection of the influenza a virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog. 2011;7:e1001329. doi: 10.1371/journal.ppat.1001329
   PubMed Web of Science ®Google Scholar
• Ivanovic T, et al. Kinetics of proton transport into influenza virions by the viral M2 channel. PLoS One. 2012;7:e31566. doi: 10.1371/journal.pone.0031566
   PubMed Web of Science ®Google Scholar
• Banerjee I, Yamauchi Y, Helenius A, et al. High-content analysis of sequential events during the early phase of influenza A virus infection. PLoS One. 2013;8:1–9.
   Web of Science ®Google Scholar
• Lin TY, et al. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep. 2013;5:895–908. doi: 10.1016/j.celrep.2013.10.033
   PubMed Web of Science ®Google Scholar
• Bailey CC, Zhong G, Huang I-C, et al. IFITM-family proteins: the cell’s first line of antiviral defense. Annu Rev Virol. 2014;1:261–283. doi: 10.1146/annurev-virology-031413-085537
   PubMed Web of Science ®Google Scholar
• Barman S, Nayak DP. Lipid raft disruption by cholesterol depletion enhances influenza A virus budding from MDCK cells. J Virol. 2007;81:12169–12178. doi: 10.1128/JVI.00835-07
   PubMed Web of Science ®Google Scholar
• Strating JRPM, et al. Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein. Cell Rep. 2015;10:600–615. doi: 10.1016/j.celrep.2014.12.054
   PubMed Web of Science ®Google Scholar
• Shim JS, Liu JO. Recent advances in drug repositioning for the discovery of new anticancer drugs. Int J Biol Sci. 2014;10:654–663. doi: 10.7150/ijbs.9224
   PubMed Web of Science ®Google Scholar
• Yarilina A, Park-Min K-H, Antoniv T, et al. TNF activates an IRF1-dependent autocrine loop leading to sustained expression of chemokines and STAT1-dependent type I interferon-response genes. Nat Immunol. 2008;9:378–387. doi: 10.1038/ni1576
   PubMed Web of Science ®Google Scholar
• Stetson DB, Medzhitov R. Type I interferons in host defense. Immunity. 2006;25:373–381. doi: 10.1016/j.immuni.2006.08.007
   PubMed Web of Science ®Google Scholar
• Baum A, Garcia-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids. 2010;38:1283–1299. doi: 10.1007/s00726-009-0374-0
   PubMed Web of Science ®Google Scholar
• Schneider WM, Chevillotte MD, Rice CM. Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol. 2014;32:513–545. doi: 10.1146/annurev-immunol-032713-120231
   PubMed Web of Science ®Google Scholar
• Carpenter AE, et al. Cellprofiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 2006;7:R100. doi: 10.1186/gb-2006-7-10-r100
   PubMed Web of Science ®Google Scholar
• Bolte S, Cordelieres FP. A guided tour into subcellular colocalisation analysis in light microscopy. J. Microsc. 2006;224:213–232. doi: 10.1111/j.1365-2818.2006.01706.x
   PubMed Web of Science ®Google Scholar
• Schindelin J, et al. Fiji : an open-source platform for biological-image analysis. Nat Methods. 2012;9:676–682. doi: 10.1038/nmeth.2019
   PubMed Web of Science ®Google Scholar